Follow
Katerina Cermakova
Katerina Cermakova
Verified email at bcm.edu
Title
Cited by
Cited by
Year
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
HC Hodges, BZ Stanton, K Cermakova, CY Chang, EL Miller, JG Kirkland, ...
Nature structural & molecular biology 25 (1), 61-72, 2018
1622018
Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif
P Tesina*, K Čermáková*, M Hořejší, K Procházková, M Fábry, S Sharma, ...
Nature communications 6 (1), 7968, 2015
602015
Next-generation drugs and probes for chromatin biology: from targeted protein degradation to phase separation
K Cermakova, HC Hodges
Molecules 23 (8), 1958, 2018
552018
BET-independent MLV-based vectors target away from promoters and regulatory elements
S El Ashkar, J De Rijck, J Demeulemeester, S Vets, P Madlala, ...
Molecular Therapy-Nucleic Acids 3, 2014
542014
Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75)
H Méreau, J De Rijck, K Čermáková, A Kutz, S Juge, J Demeulemeester, ...
Leukemia 27 (6), 1245-1253, 2013
532013
Validation and structural characterization of the LEDGF/p75–MLL interface as a new target for the treatment of MLL-dependent leukemia
K Čermáková, P Tesina, J Demeulemeester, S El Ashkar, H Mereau, ...
Cancer research 74 (18), 5139-5151, 2014
522014
A ubiquitous disordered protein interaction module orchestrates transcription elongation
K Cermakova, J Demeulemeester, V Lux, M Nedomova, SR Goldman, ...
Science 374 (6571), 1113-1121, 2021
402021
Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation
S Sharma*, K Čermáková*, J De Rijck, J Demeulemeester, M Fábry, ...
Proceedings of the National Academy of Sciences 115 (30), E7053-E7062, 2018
352018
Interaction modules that impart specificity to disordered protein
K Cermakova, HC Hodges
Trends in biochemical sciences 48 (5), 477-490, 2023
242023
Structure of the effector-binding domain of the arabinose repressor AraR from Bacillus subtilis
K Procházková, K Čermáková, P Pachl, I Sieglová, M Fábry, Z Otwinowski, ...
Acta Crystallographica Section D: Biological Crystallography 68 (2), 176-185, 2012
232012
SWI/SNF blockade disrupts PU.1-directed enhancer programs in normal hematopoietic cells and acute myeloid leukemia
C Chambers, K Cermakova, YS Chan, K Kurtz, K Wohlan, AH Lewis, ...
Cancer research 83 (7), 983-996, 2023
152023
Lessons learned: HIV points the way towards precision treatment of mixed-lineage leukemia
K Cermakova, C Weydert, F Christ, J De Rijck, Z Debyser
Trends in pharmacological sciences 37 (8), 660-671, 2016
122016
The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and disorder
K Cermakova, V Veverka, HC Hodges
Biochemical Society Transactions 51 (1), 125-135, 2023
72023
Molecular mechanism of LEDGF/p75 dimerization
V Lux, T Brouns, K Čermáková, P Srb, M Fabry, M Mádlíková, M Hořejší, ...
Structure 28 (12), 1288-1299. e7, 2020
72020
Dynamics of transcription-dependent H3K36me3 marking by the SETD2: IWS1: SPT6 ternary complex
K Cermakova, EA Smith, V Veverka, HC Hodges
BioRxiv, 636084, 2019
72019
Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF
K Cermakova, L Tao, M Dejmek, M Sala, MD Montierth, YS Chan, I Patel, ...
Nucleic Acids Research 52 (1), 4-21, 2024
22024
SMARCA4 regulates spatially restricted metabolic plasticity in 3D multicellular tissue
K Cermakova, EA Smith, YS Chan, ML Cabrera, C Chambers, MI Jarvis, ...
bioRxiv, 2021.03. 21.436346, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–17